Advanced Search

Science is at the core of what we do at Philip Morris International (PMI). So far we have invested over 7.2 billion USD  in fundamental research, product development, scientific substantiation, and manufacturing capacity of our smoke-free products – products which are better alternatives to cigarettes for those adult smokers who would otherwise continue to smoke. We know our science stands up to scrutiny, and we openly share it with the scientific community, regulators, and the general public.

Our September event about the differences between heated tobacco aerosol and cigarette smoke is ended. Stay tuned for information about upcoming events!

 

Open Science events archive

In case you missed it, you can check out the presentations and information related to all our Open Science events at the links below.

Smoke vs aerosol blue

September 2020

testubes thumb

June 2020

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.